Source: Read Full Article

CHICAGO (Reuters) – When COVID-19 hit in 2020, Ghenya Grondin of Waltham, Massachusetts, was a postpartum doula – a person charged with helping young couples navigate the first weeks of their newborn child’s life at home. Grondin, now aged 44, was infected with SARS-CoV-2 in mid-March of that year – before there were tests, before social distancing or masks, and […]

HONOLULU, Hawaii — In the clinical experience of John S. Barbieri, MD, MBA, cheilitis occurs in nearly all patients taking any dose of isotretinoin. “If they don’t have dry lips, you have to wonder if they’re even absorbing isotretinoin,” Barbieri, director of the Advanced Acne Therapeutics Clinic at Brigham and Women’s Hospital, Boston, said at the Hawaii Dermatology Seminar provided […]

Researchers from Oregon Health & Science University and institutions across the country have identified a pill used to treat a common skin disease as an “incredibly promising” treatment for alcohol use disorder. Their study was recently published in the Journal of Clinical Investigation. On average, the people who received the medication, called apremilast, reduced their alcohol intake by more than […]

A global strategy is launched today to coordinate the complex research activities necessary for a new approach to coronavirus vaccine development. The aim is to develop more effective, longer lasting vaccines against continually emerging SARS-CoV-2 variants, and against new coronaviruses that may emerge in the future. The Coronavirus Vaccines Research and Development Roadmap (CVR) is led by the US Center […]

In a bid to understand why mosquitoes may be more attracted to one human than another, Johns Hopkins Medicine researchers say they have mapped specialized receptors on the insects' nerve cells that are able to fine-tune their ability to detect particularly "welcoming" odors in human skin. Receptors on mosquito neurons have an important role in the insects' ability to identify […]

Three years into the COVID-19 pandemic, new variant outbreaks continue to fuel economic disruptions and hospitalizations across the globe. Effective therapies remain unavailable in much of the world, and circulating variants have rendered monoclonal antibody treatments ineffective. But a new analysis shows how convalescent plasma can be used as an effective and low-cost treatment both during the COVID-19 pandemic and […]

Source: Read Full Article

An analysis of a COVID-19 trial has found that a combination of symptoms and viral rebound after untreated COVID-19 infection is rare, occurring in only 3% of study participants. The analysis is published in Annals of Internal Medicine. Nirmatrelvir–ritonavir is a recommended treatment for outpatients with mild to moderate COVID-19 and risk factors for severe disease. Widespread use of nirmatrelvir […]